Oral alkali therapy ( NaHCO3 ) to maintain serum bicarbonate levels between [...] mmol/L) reduces the risk of progression of chronic kidney disease.
Answer
23 and 29 mEq/L (23-29
Question
Oral alkali therapy ( NaHCO3 ) to maintain serum bicarbonate levels between [...] mmol/L) reduces the risk of progression of chronic kidney disease.
Answer
?
Question
Oral alkali therapy ( NaHCO3 ) to maintain serum bicarbonate levels between [...] mmol/L) reduces the risk of progression of chronic kidney disease.
Answer
23 and 29 mEq/L (23-29
If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open it Oral alkali therapy ( NaHCO3 ) to maintain serum bicarbonate levels between 23 and 29 mEq/L (23-29 mmol/L) reduces the risk of progression of chronic kidney disease.
Original toplevel document (pdf)
owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p3603
Summary
status
not learned
measured difficulty
37% [default]
last interval [days]
repetition number in this series
0
memorised on
scheduled repetition
scheduled repetition interval
last repetition or drill
Details
No repetitions
Discussion
Do you want to join discussion? Click here to log in or create user.